Notice of Intent - Xpert Xpress CoV-2/Flu/RSV plus

The Indian Health Service, Navajo Area, Shiprock Service Unit intends to restrict competition and negotiate an award with Cepheid for the Xpert Xpress CoV-2/Flu/RSV Plus test kits. The projected period of performance is from January 1, 2026, to December 31, 2030, with multiple option periods. The applicable NAICS code is 325413, In-Vitro Diagnostic Substance Manufacturing. Key aspects of this opportunity include: • The Indian Health Service is seeking to procure Xpert Xpress CoV-2/Flu/RSV Plus test kits • The procurement is intended to be a sole-source award to Cepheid • The period of performance is approximately 60 months, with multiple option periods • The applicable NAICS code is 325413, In-Vitro Diagnostic Substance Manufacturing